ArticleCancer cell international2022

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma.

Ye Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.